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ABSTRACT 
Objectives: To assess the awareness of healthcare providers in Sana’a city of the most frequently antibi-
otic-resistant bacterial isolates encountered in clinical settings, the factors associated with the emergence 
of such resistance and the strategies to counteract antibiotic resistance. 
Methods: This cross-sectional study included 416 healthcare providers; namely, 167 physicians, 61 phar-
macists and 188 nurses, from four public and two private hospitals in Sana’a. Data about demographics, 
awareness of the most frequently isolated antibiotic-resistant bacteria in clinical settings, the factors pos-
sibly associated with such resistance and the best strategies to counteract antibiotic resistance were col-
lected using a pre-designed questionnaire. Data were then analyzed using suitable statistical tests. 
Results: The majority of healthcare providers were aware of methicillin-resistant Staphylococcus aureus 
and Pseudomonas aeruginosa as the two most frequently encountered bacterial species in clinical practice, 
with non-statistically significant differences in the awareness level among physicians, pharmacists and 
nurses. However, a statistically significant difference was found among healthcare providers regarding 
their awareness of the most possible factors contributing to antibiotic resistance. In this regard, pharma-
cists were significantly more aware of the contribution of the extensive use of newer generations of antibi-
otics (P = 0.030), inappropriate prescribing of antibiotics (P = 0.010) and use of antibiotics without pre-
scription (P = 0.045) to the emergence and spread of antibiotic resistance than physicians and nurses. On 
the other hand, physicians and nurses were significantly more aware of the role of reducing the length of 
hospital stay (P = 0.005), limiting the use of medical instrumentation (P = 0.036), use of narrow-spectrum 
antibiotics (P = 0.005), surveillance for antibiotic resistance (P = 0.004), development of infection control 
policies and procedures (P <0.001) and consultation with infectious disease specialists (P = 0.010) as key 
strategies to minimize the emergence of antibiotic-resistant bacteria compared to pharmacists. Moreover, 
nurses showed significantly higher awareness of the use of narrow-spectrum antibiotics (P = 0.005) and 
surveillance of antibiotic resistance (P = 0.003) as key strategies to reduce the emergence and spread of 
antibiotic resistance. 
Conclusions: There is a discrepancy in the awareness of Yemeni healthcare providers’ of the most fre-
quently encountered antibiotic-resistant bacteria in clinical practice, the factors possibly contributing to 
such resistance and the key strategies to counteract it. Therefore, continuing medical education of physi-
cians, pharmacists and nurses is recommended to keep them updated on antibiotic resistance and the best 
strategies and approaches to its containment. In addition, there is a need for the development of infectious 
disease protocols for hospitals to optimize the selection and treatment with antibiotics, to reduce side ef-
fects and costs and to minimize the development of antibiotic resistance. 
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1. Introduction 
Antibiotics are one of the most commonly pre-
scribed medications worldwide, and the majority 
of such medications are mainly prescribed out-
side the hospital setting in community pharma-
cies (1, 2). Treatment of infectious diseases 
caused by resistant microorganisms contributes 
to a considerable increase in treatment costs, 
disease spread, illness duration and mortality 
rate (3). Therefore, the emergence of bacterial 
strains resistant to antibiotics represents a major 
public health problem (4). 
Multidrug resistance (MDR) in bacteria re-
fers to their resistance to three or more agents 
from different categories of antibiotics, mainly 
antipseudomonal penicillin, aminoglycosides, 
cephalosporins, carbapenems, and quinolones (5, 
6). MDR bacteria of special concern to healthcare 
facilities include methicillin-resistant Staphylo-
coccus aureus (MRSA), vancomycin-resistant En-
terococcus(VRE), extended-spectrum beta-
lactamase (ESBL)-producing Gram-negative bac-
teria, Pseudomonas aeruginosa and Acinetobacter 
baumannii (7). Several risk factors have been 
linked to the emergence and spread of MDR bac-
teria. These include prolonged hospitalization, 
invasive procedures, exposure to broad-
spectrum antibiotics, non-adherence to infection 
control guidelines, inadequate surveillance sys-
tem and unhygienic conditions (8–12). In addi-
tion, irrational use of antimicrobials is one of the 
major drivers for antibiotic resistance, especially 
in developing countries (13). In Yemen, easy 
over-the-counter obtaining of antibiotics from 
pharmacies (14,15) and physicians non-
adherence to rational prescribing of antibiotics 
(16, 17) are among the factors that contribute to 
the emergence of resistant bacteria. 
Therefore, the present study aimed to assess 
healthcare providers’ awareness of the most fre-
quently encountered antibiotic-resistant bacteria, 
the factors contributing to such resistance and the 
key strategies to counteract it in Sana’a city. 
2. Methods 
2.1. Study design, setting and sample size calcula-
tion  
This was a cross-sectional study among physi-
cians, pharmacists and nurses working in public 
and private hospitals of Sana’a city during April 
2016. Healthcare providers were recruited from 
four public hospitals; namely, Al-Thawra Modern 
General Hospital (TMGH), Al-Jomhori Teaching 
Hospital (GTH), Kuwait University Hospital 
(KUH) and Al-Sabeen Maternal Hospital (SMH) 
and two private hospitals, University of Science 
and Technology Hospital and Saudi German Hos-
pital. A sample size of 383 was calculated using 
OpenEpi 
(http://www.openepi.com/SampleSize/SSPropo
r.htm) after applying the default parameters and 
their values such as population size, anticipated 
% frequency, confidence limit and design effect 
were used. A number of 167 questionnaires  
were added to overcome non-respondents 
healthcare providers and to give a better chance 
to collect the required sample size. 
2.2. Data collection 
Data was collected using a pre-designed ques-
tionnaire composed of four sections (18). Modifi-
cations were made by the authors and then dis-
tributed to five PhD holders from the Faculty of 
Pharmacy, Al-Nasser University and University of 
Science and Technology as part of validation. All 
comments were considered before starting the 
study. Questionnaires were administered and 
collected through hospital visits, where partici-
pants were approached at their offices or rest ar-
eas and asked to complete the four questionnaire 
sections. The first section included questions 
about the respondent’s demographic data includ-
ing gender, age, occupation, level of education 
and specialty. In the second section, the partici-
pants were asked to answer questions regarding 
the most likely encountered antibiotic-resistant 
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bacterial species. The participants had to rate six 
different bacterial strains known to have the 
ability to develop resistance to antibiotics includ-
ing MRSA, VRE-faecium, VRE-faecalis, ESBL-
producing Gram-negative bacteria, P. aeruginosa 
and A. baumannii. In the third and fourth sec-
tions, the respondents were asked to rate 12 fac-
tors that contribute to the emergence of bacterial 
resistance to antibiotics and 12 strategies that 
may reduce the development of such resistance. 
A four-level scale was used to rate responses as 
follows: 1, very unlikely; 2, somewhat unlikely; 3, 
somewhat likely; 4, very likely.  
2.3. Statistical analysis 
Data were analyzed using IBM SPSS Statistics 
version 21.0 for Windows® (IBM Corp., Armonk, 
NY, USA). One-way analysis of variance (ANOVA) 
followed by Bonferroni post-hoc test was used to 
compare between the mean scores of independ-
ents groups for normally distributed data. On the 
other hand, non-normally distributed data were 
analyzed using Kruskal-Wallis test.  
3. Results 
3.1. Characteristics of participating healthcare 
providers 
Out of 550 healthcare providers invited to partic-
ipate, 518 (94%) responded to the study. How-
ever, only 416 questionnaires were filled proper-
ly and subsequently used in the study. Table (1) 
shows that the majority of participants were 
males (56.7%; 236/416), working in public hos-
pitals (78.8%; 318/416) and aged less than 30 
years (51.9%; 216/416). Details of the education 
levels and medical specialties of the participants 
are shown in Table (1). 
3.2. Healthcare providers’ awareness of the most 
frequent antibiotic-resistant bacterial strains and 
the factors possibly associated with antibiotic re-
sistance 
There were no statistically significant differences 
among physicians, pharmacists and nurses re-
garding their awareness of the most frequently 
encountered antibiotic-resistant bacteria in clini-
cal practice (Table 2). However, there were sta-
tistically significant differences among physi-
cians, pharmacists and nurses with respect to 
their awareness of the probable contribution of 
the extensive use of newer generations of antibi-
otics (P = 0.036), inappropriate prescribing of 
antibiotics (P = 0.020), use of antibiotic without 
prescription (P = 0.015) and economic and polit-
ical factors (P = 0.043) to the development of an-
tibiotic resistance (Table 3). The Bonferroni 
post-hoc test revealed that pharmacists were 
significantly more aware of the contribution of 
the extensive use of newer generations of antibi-
otics (P = 0.030), inappropriate prescribing of 
antibiotics (P = 0.010) and the use of antibiotics 
without prescription (P = 0.045) to antibiotic re-
sistance than physicians and nurses. On the other 
hand, physicians showed statistically higher 
awareness of the probable contribution of using 
antibiotics without prescription (P = 0.009) and 
economic and political factors (P = 0.040) to the 
development of antibiotic resistance compared 
to nurses and pharmacists. 
3.3. Healthcare providers’ awareness of the strate-
gies to counteract antibiotic resistance 
Regarding the appropriate strategies to limit the 
development of antibiotic resistance, Table (4) 
shows statistically significant differences among 
physicians, pharmacists and nurses with respect 
to their awareness of the utility of the following 
strategies to counteract the emergence of antibi-
otic resistance: reducing the length of hospital 
stay (P = 0.005), limiting the use of medical in-
strumentation (P = 0.036), use of narrow-
spectrum antibiotics (P = 0.005), surveillance for 
antibiotic resistance (P = 0.004), development of 
infection control policies and procedures (P 
<0.001) and consultation with infectious disease 
specialists (P = 0.010). Bonferroni post-hoc test 
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revealed that physicians had significantly higher 
awareness of the following strategies to reduce 
the risk of the emergence of antibiotic-resistant 
bacterial strains: reducing the length of hospital 
stay (P = 0.005), development of infection con-
trol policies and procedures (P = 0.001) and con-
sultation with infectious disease specialists (P = 
0.032). On the other hand, nurses were signifi-
cantly more knowledgeable than pharmacists re-
garding the following strategies: reducing the 
length of hospital stay (P = 0.007) and develop-
ment of infection control policies and proce-
dures. Moreover, nurses showed significantly 
higher awareness of the use of narrow-spectrum 
antibiotics (P = 0.005) and surveillance of antibi-
otic resistance (P = 0.003) as key strategies to 
reduce the emergence and spread of antibiotic 
resistance.
Table 1: Characteristics of participating healthcare providers working in hospitals of Sana’a city, Yemen in 2016 (N = 416) 
Characteristic Physicians Pharmacists Nurses Total 
n (%) n (%) n (%) n (%) 
Hospital TMGH 51 (30.5) 14 (23.0) 58 (30.9) 123 (29.6) 
GTH 39 (23.4) 20 (32.8) 26 (13.8) 85 (20.4) 
SMH 30 (18.0) 6 (9.8) 28 (14.9) 64 (15.4) 
KUH 10 (6.0) 10 (16.4) 36 (19.1) 56 (13.5) 
USTH 17 (10.2) 6 (9.8) 20 (10.6) 43 (10.3) 
SGH 20 (12.0) 5 (8.2) 20 (10.6) 45 (10.8) 
Hospital type          
Public 130 (62.3)  50 (82.0)  148 (78.7)  328 (78.8)  
Private 37 (37.7)  11 (18.0)  40 (21.3)  88 (21.2)  
Gender         
 
 
 
Male 104 (62.3)  40 (65.6)  92 (48.9)  236 (56.7)  
Female 63 (37.7)  21 (34.4)  96 (51.1)  180 (43.3)  
 < 30 59 (35.3)  28 (45.9)  129 (68.6)  216 (51.9)  
30–40 66 (39.5)  29 (47.5)  54 (28.7)  149 (35.8)  
> 40 42 (25.1)  4 (6.6)  5 (2.7)  51 (12.3)  
Occupation         
 Physician (consultant) 20 (12.0)  -   -   20 (4.8)  
Physician (specialist) 53 (31.7)  -   -   53 (12.7)  
Physician (resident) 37 (22.2)  -   -   37 (8.9)  
Physician (general practitioner) 57 (34.1)  -   -   57 (13.7)  
Pharmacist (diploma) -   16 (26.2)   -   16 (3.8)  
Pharmacist (bachelor) -   42 (68.9)   -   42 (10.1)  
Pharmacist (master) -   3 (4.9)   -  3 (0.7)  
Nurse (diploma) -   -   107 (56.9)  107 (25.7)  
Nurse (bachelor) -   -   75 (39.9)  75 (18.0)  
Nurse (master) -   -   6 (3.2)  6 (1.40)  
Total  - 167 (40.1)   66 (14.7)   188 (45.2)  416 (100)  
TMGH, Al-Thawra Modern General Hospital; GTH, Al-Jomhori Teaching Hospital; KUH, Kuwait University Hospital; SMH, Al-Sabeen Maternal Hospital; USTH, 
University of Science and Technology Hospital; SGH, Saudi German Hospital.
  
© 2018 University of Science and Technology, Sana'a, Yemen. This article can be unrestrictedly used, distributed or reproduced in 
any medium, provided that credit is given to the authors and the journal.  
16 
Halboup et al., Yemeni J Med Sci 2018; 12-21 
https://doi.org/10.20428/YJMS.12.1.A2 
Table 2. Healthcare providers’ awareness of the most frequently encountered antibiotic-resistant bacterial strains in clinical practice in Sana’a city, 
Yemen in 2016 (N = 416) 
Bacterial strain Category of healthcare 
provider 
n (%) Awareness score 
(mean ± SD) 
F-statistic P-value 
MRSA Physician 167 (40.1) 207 a ± 0.748  
3.11b 
 
 
 
0.211# 
 
 
Pharmacist 61 (14.7) 230 a ± 0.719 
Nurse 188 (45.2) 202 a ± 0.838 
VRE-faecium Physician 167 (40.1) 1.86 ± 0.965  
1.208 
 
 
0.300 
 
  
Pharmacist 61 (14.7) 1.80 ± 0.853 
Nurse 188 (45.2) 1.98 ± 0.901 
VRE-faecalis Physician 167 (40.1) 204 a ± 0.883  
0.501b 
 
 
0.778# 
 
  
Pharmacist 61 (14.7) 215 a ± 0.885 
Nurse 188 (45.2) 209 a ± 0.848 
ESBL-producing Gram-negative 
bacilli  
Physician 167 (40.1) 1.92 ± 0.776  
1.134 
 
 
0.323 
 
  
Pharmacist 61 (14.7) 1.92 ± 0.759 
Nurse 188 (45.2) 1.80 ± 0.893 
Pseudomonas aeruginosa Physician 167 (40.1) 2.26 ± 0.830  
2.055 
 
0.129 
 
 
Pharmacist 61 (14.7) 2.23 ± 0.783 
Nurse 188 (45.2) 2.09 ± 0.898 
Acinetobacter baumannii Physician 167 (40.1) 1.80 ± 0.983  
0.428 
 
0.652 Pharmacist 61 (14.7) 1.67 ± 0.870 
Nurse 188 (45.2) 1.75 ± 0.968 
#, Analyzed using Kruskal-Wallis test; a, mean rank; b, value for chi-square; MRSA, methicillin-resistant S. aureus; VRE, Vancomycin-resistant Enterococcus; ESBL, ex-
tended-spectrum β-lactamase-producing Gram-negative bacilli; SD, standard deviation. 
4. Discussion 
The awareness of the majority of healthcare pro-
viders in the present study about MRSA and P. ae-
ruginosa as being the most frequently isolated an-
tibiotic-resistant bacteria in clinical settings is 
consistent with previous findings that both spe-
cies are the most frequently isolated bacteria 
among Yemen patients with otitis media (19, 20). 
It is worth mentioning that the European Antimi-
crobial Resistance Surveillance Network specifies 
these two species among the seven resistant mi-
croorganisms commonly reported in several Eu-
ropean countries (21). In addition, a recent study 
among Iraqi pharmacists revealed that MRSA was 
the most frequently isolated resistant bacterial 
strain (22).  
In Yemen, the pattern of antibiotic prescrip-
tion in the ambulatory care of public hospitals 
was high compared to the incidence of infectious 
diseases, where up to 51% of all prescriptions in-
clude antibiotics 16). Moreover, antibiotics in 
Yemen can be easily obtained from pharmacies 
without prescription (23), and such over-
prescription of antibiotics is one of the major risk 
factors for the development of resistance. The 
present study revealed that healthcare providers 
conceived that the extensive use of antibiotics, in-
appropriate antibiotic prescribing and use of an-
tibiotics without prescription are major factors 
contributing to the emergence of antibiotic-
resistant bacterial strains. This result is con-
sistent with other studies reporting that inappro-
priate and over-prescription of antibiotics are 
leading causes of bacterial resistance to antibiot-
ics (18,24–28). Similarly, a recent study in hospi-
tal and community pharmacies in Iraq showed 
that the use of antibiotics without prescription is 
a significant reason for the development of bacte-
rial resistance to antibiotics (22). On the other 
hand, the awareness of Yemeni physicians of the 
contribution of economic and political situations 
to the emergence and spread of antibiotic re-
sistance is in agreement with a study conducted 
in 28 European countries, which indicated that 
corruption and poor governance are contributors 
to the development of antibiotic resistance (29). 
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Table 3. Healthcare providers’ awareness of the most probable factors contributing to the emergence and spread of antibiotic resistance in Sana’a 
city, Yemen in 2016 (N = 416) 
Risk factors associated with antibiotic resistance   Awareness score   
N (%) Mean± SD F-statistic P-value 
Prolonged hospitalization Physician 167 (40.1) 217 a ± 0.650   2.537b 0.281# 
Pharmacist 61 (14.7) 198 a ± 0.808   
Nurse 188 (45.2) 204 a ± 0.831   
     
Exposure to contaminated medical instruments  Physician 167 (40.1) 2.23 ± 0.890 1.548 0.214 
Pharmacist 61 (14.7) 2.34 ± 0.772   
Nurse 188 (45.2) 2.39 ± 0.880   
     
Extensive use of newer generations of antibiotics Physician 167 (40.1) 194 a ± 0.809 6.642b 0.036*# 
Pharmacist 61 (14.7) 230 a ± 0.544   
Nurse 188 (45.2) 214 a ± 0.756   
     
Inappropriate infection control practice Physician 167 (40.1) 2.14 ± 0.778 1.181 0.308 
Pharmacist 61 (14.7) 2.15 ± 0.771   
Nurse 188 (45.2) 2.27 ± 0.830   
     
Inappropriate prescribing of antibiotics Physician 167 (40.1) 207 a ± 0.778 7.813b 0.020*# 
Pharmacist 61 (14.7) 245 a ± 0.629   
Nurse 188 (45.2) 199 a ± 0.929   
     
Ineffective surveillance system Physician 167 (40.1) 2.06 ± 0.819 0.116 0.890 
Pharmacist 61 (14.7) 2.05 ± 0.784   
Nurse 188 (45.2) 2.02 ± 0.951   
     
Use of antibiotics without prescription Physician 167 (40.1) 220 a ± 0.798 8.400b 0.015*# 
Pharmacist 61 (14.7) 227 a ± 0.788   
Nurse 188 (45.2) 192 a ± 1.033   
     
Crowding and unhygienic conditions Physician 167 (40.1) 2.04 ± 0.894 4.262b 0.119# 
Pharmacist 61 (14.7) 1.89 ± 0.915   
Nurse 188 (45.2) 2.12 ± 0.985   
     
Non-adherence of practitioners to treatment guide-
lines 
Physician 167 (40.1) 2.07 ± 0.899 0.677 0.509 
Pharmacist 61 (14.7) 2.07 ± 0.814   
Nurse 188 (45.2) 2.17 ± 0.949   
     
Inappropriate hand hygiene Physician 167(40.1) 204 a ± 0.813 4.217b 0.121# 
Pharmacist 61(14.7) 187 a ± 0.904   
Nurse 188(45.2) 219 a ± 0.941   
     
Patient non-compliance Physician 167 (40.1) 211 a ± 0.711 0.402b 0.818# 
Pharmacist 61 (14.7) 201 a ± 0.859   
Nurse 188 (45.2) 208 a ± 0.862   
     
Economic and political factors Physician 167 (40.1) 218 a ± 0.926 6.270b 0.043*# 
Pharmacist 61 (14.7) 176 a ± 0.989   
Nurse 188 (45.2) 210 a ± 1.002   
*, Statistically significant at P < 0.05; #, analyzed using Kruskal-Wallis test; SD, standard deviation; a, mean rank; b, value for chi-square.
Nosocomial infections continue to be a major 
health problem in both developed and developing 
countries. The significance of such infections is 
not only attributed to the increase in morbidity 
and mortality rates but also to the emergence of 
antimicrobial resistance, prolonged hospitaliza-
tion, increased healthcare cost and reduced 
treatment success (30–32). In this context, the 
present study revealed statistically non-
significant differences among various categories 
of healthcare providers regarding their aware-
ness of the major role of prolonged hospitaliza-
tion as a contributing factor possibly associated 
with the emergence of antibiotic resistance. Simi-
larly, awareness of prolonged hospitalization as a 
contributor to antibiotic resistance was also re-
ported among Ethiopian physicians, pharmacists 
and nurses (27). 
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Table 4: Healthcare providers’ awareness of the strategies to counteract the development of antibiotic resistance in Sana’a city, Yemen in 2016 (N = 
416) 
Strategies to counteract bacterial resistance  Awareness scores   
n (%) Mean ± SD F-statistic P-value 
Appropriate infection control practice  Physician 167 (40.1) 211 a ± 0.558 2.902b 0.234# 
Pharmacist 61 (14.7) 190 a ± 0.696   
Nurse 188 (45.2) 212 a ± 0.589   
     
Reducing the length of hospital stay Physician 167 (40.1) 2.49 ± 0.629 5.370 0.005* 
Pharmacist 61 (14.7) 2.20 ± 0.726   
Nurse 188 (45.2) 2.49 ± 0.633   
     
Limiting the use of medical instrumentation Physician 167 (40.1) 2.12 ± 0.849 3.351 0.036* 
Pharmacist 61 (14.7) 2.08 ± 0.666   
Nurse 188 (45.2) 2.31 ± 0.809   
     
Use of narrow-spectrum antibiotics Physician 167 (40.1) 2.04 ± 0.809 5.357 0.005* 
Pharmacist 61 (14.7) 2.26 ± 0.603   
Nurse 188 (45.2) 2.30 ± 0.787   
     
Surveillance for antibiotics resistance Physician 167 (40.1) 2.18 ± 0.965 5.716 0.004* 
Pharmacist 61 (14.7) 2.43 ± 0.787   
Nurse 188 (45.2) 2.48 ± 0.763   
     
Review of antibiotic utilization and its relationship 
to local antibiotic resistance patterns 
Physician 167 (40.1) 2.29 ± 0.838 1.679 0.188 
Pharmacist 61 (14.7) 2.36 ± 0.817   
Nurse 188 (45.2) 2.45 ± 0.733   
     
Encouragement of the practice of bacterial isolation 
and susceptibility testing 
Physician 167 (40.1) 2.54 ± 0.742 2.609 0.075 
Pharmacist 61 (14.7) 2.28 ± 0.819   
Nurse 188 (45.2) 2.49 ± 0.777   
     
Better adherence to treatment guidelines Physician 167 (40.1) 201 a ± 0.656 3.196b 0.202# 
Pharmacist 61 (14.7) 190 a ± 0.766   
Nurse 188 (45.2) 218 a ± 0.673   
     
Discouragement of self-treatment with antibiotics Physician 167 (40.1) 209 a ± 0.926 3.829b 0.147# 
Pharmacist 61 (14.7) 185 a ± 0.767   
Nurse 188 (45.2) 216 a ± 0.781   
     
Educational programs for healthcare providers and 
the community 
Physician 167(40.1) 2.29 ± 0.777 1.268 0.282 
Pharmacist 61(14.7) 2.23 ± 0.739   
Nurse 188(45.2) 2.39 ± 0.797   
     
Development of infection control policies and proce-
dures 
Physician 167 (40.1) 211 a ± 0.610 18.124b <0.001*# 
Pharmacist 61 (14.7) 157 a ± 0.703   
Nurse 188 (45.2) 223a ± 0.665   
     
Consultation with infectious disease specialists Physician 167 (40.1) 2.58 ± 0.643 3.752 0.010* 
Pharmacist 61 (14.7) 2.31 ± 0.672   
Nurse 188 (45.2) 2.44 ± 0.761   
     
*, Statistically significant at P < 0.05; #, analyzed using Kruskal-Wallis test was used; SD, standard deviation; a, rank; b, value for chi-square.
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Variations in responses of various catego-
ries and specialties of healthcare providers re-
garding the factors possibly contributing to the 
emergence of antibiotic resistance in the pre-
sent study might be attributed to different edu-
cational backgrounds and practice settings. 
Pharmacists, for example, reported that using 
antibiotics without prescription, inappropriate 
prescribing of antibiotics and extensive use of 
newer generations of antibiotics are the most 
likely factors contributing to the emergence of 
resistant bacteria. In the present study, physi-
cians reported that using antibiotics without 
prescription in addition to economic and politi-
cal factors are the factors contributing to anti-
biotic resistance. On the other hand, physicians 
and nurses indicated that prolonged hospitali-
zation is the leading cause of antibiotic re-
sistance, reflecting their close contact during 
clinical practice (order and implementation re-
lationship). Physicians also reported that using 
antibiotics without prescription contributes to 
such resistance, highlighting the importance of 
taking a medication after obtaining the right di-
agnosis and legal drug prescription from a phy-
sician. 
Identifying the factors responsible for the 
emergence of bacterial resistance to antibiotics 
is critical to the adoption of effective strategies 
to minimize or slow down the emergence of 
such resistance. Since nosocomial infections are 
associated with high mortality rates, poor clini-
cal outcomes and development of antibiotic re-
sistance, hospitals should take serious actions 
to minimize the emergence of antibiotic re-
sistance. In this context, healthcare providers in 
the present study suggested that the implemen-
tation of appropriate infection control practice, 
encouragement of bacterial isolation in culture 
and susceptibility testing, better adherence to 
treatment guidelines, reducing the length of 
hospital stays, surveillance for antibiotic re-
sistance and consultations with infectious dis-
ease specialists as the most likely strategies to 
control the emergence of nosocomial antibiotic 
resistance. In line with these findings, it is well 
documented that appropriate use of antimicro-
bials, reinforcement of basic infection control 
measures, improved hand hygiene, surveillance 
for antibiotic resistance and consultation with 
infectious disease specialists are key strategies 
for counteracting antimicrobial resistance (28, 
31, 33–42).  
The differences in the levels of healthcare 
providers’ awareness according to their special-
ties in the present study could be generally at-
tributed to the differences in their educational 
backgrounds and the working environments. In 
this regard, physicians and nurses were signifi-
cantly more aware than pharmacists of the role 
of reducing the lengths of hospital stay, practice 
of infection control policies and procedures and 
consultation with infectious disease specialists 
as key strategies to minimize the development 
of antimicrobial resistance. This finding is con-
sistent with those reported in other studies, 
which  revealed  a number of discrepancies in 
the awareness level between healthcare provid-
ers with respect to the most isolated resistant 
bacteria, factors that contribute to such re-
sistance and the strategies that can be used to 
counteract such resistance (18, 27). 
5. Conclusions  
Healthcare providers in Yemen show a discrep-
ancy in their awareness of the most frequently 
encountered antibiotic-resistant bacteria in clin-
ical practice. In addition, their awareness is var-
iable regarding the factors possibly contributing 
to the emergence and spread of bacterial re-
sistance to antibiotics as well as the key strate-
gies that can help to counteract such resistance. 
Therefore, continuing medical education of phy-
sicians, pharmacists and nurses is recommend-
ed to keep them updated on antibiotic resistance 
and the best strategies and approaches to its 
containment. In addition, there is a need for the 
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development of infectious disease protocols for 
hospitals to optimize the selection and treat-
ment with antibiotics, reduce side effects and 
cost and minimize the development of bacterial 
resistance to antibiotics. 
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